Citation Impact
Citing Papers
Infection, inflammation, height, and longevity
2005 Standout
Epidemiology and causes of preterm birth
2008 Standout
Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis
2009
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Emerging Mechanisms of Fluoroquinolone Resistance
2001
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
The metabolic syndrome
2010 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
C-reactive protein and body mass index in children: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994
2001
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
2004 Standout
C-reactive protein: a critical update
2003 Standout
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling
2002
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Obesity
2005 Standout
10-Year Research Update Review: The Epidemiology of Child and Adolescent Psychiatric Disorders: II. Developmental Epidemiology
2005
The metabolic syndrome
2005 Standout
Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, ≥30)
2002
Identification of Periodontal Pathogens in Atheromatous Plaques
2000
Influence of Personal Exposure to Particulate Air Pollution on Cardiovascular Physiology and Biomarkers of Inflammation and Oxidative Stress in Subjects With Diabetes
2007
Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease
2002
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
2008
Relation between markers of systemic vascular inflammation and smoking in women
2002
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis
2001
Dyslipidemia and inflammation: an evolutionary conserved mechanism
2005
Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease
2004
Fluoroquinolones: Action and Resistance
2003
Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
2004 Standout
Depression in adolescence
2012 Standout
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Commentary: Adjustment for potential confounders may have been taken too far
2000
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease
2009
Mental health of young people: a global public-health challenge
2007 Standout
Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children
2002
The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease — baseline findings of the PAIS project
2001
IgG4-related disease
2014 Standout
Periodontal diseases
2005 Standout
Elevation of Systemic Markers Related to Cardiovascular Diseases in the Peripheral Blood of Periodontitis Patients
2000
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Mechanisms of Resistance to Quinolones
2005
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Mechanism of Quinolone Action and Resistance
2014 Standout
Biomarkers in Heart Failure
2008 Standout
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
2000
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men
2002
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Synthesis of phenoxyquinolin-4(1H)-one through copper(II)-mediated cross-coupling of phenylboronic acid and hydroxyquinolin-4(1H)-one
2005
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women
1999
Probing the Differential Interactions of Quinazolinedione PD 0305970 and Quinolones with Gyrase and Topoisomerase IV
2009
Elevated C-Reactive Protein
2001
C-Reactive Protein Concentration and Cardiovascular Disease Risk Factors in Children
2003
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Inflammation and Atherosclerosis
2002 Standout
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
C-Reactive Protein and Features of the Metabolic Syndrome in a Population-Based Sample of Children and Adolescents
2004
Potential Role of Ultrafine Particles in Associations between Airborne Particle Mass and Cardiovascular Health
2005
Association of Low Interleukin-10 Levels with the Metabolic Syndrome in Obese Women
2003
Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study
2013
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
C-Reactive Protein in Heart Failure
2005
Quinolone Resistance Mutations in Streptococcus pneumoniae GyrA and ParC Proteins: Mechanistic Insights into Quinolone Action from Enzymatic Analysis, Intracellular Levels, and Phenotypes of Wild-Type and Mutant Proteins
2001
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
C-reactive protein: a critical update
2003 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure
2002
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year
2002
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction
1999 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches
2013
Occurrence of sialic acids in healthy humans and different disorders
1999
Works of Julia E. Morris being referenced
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors
2000
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study Commentary: Chlamydia pneumoniae infection and ischaemic heart disease
1999
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.
1997
Cleavable-Complex Formation by Wild-Type and Quinolone-Resistant Streptococcus pneumoniae Type II Topoisomerases Mediated by Gemifloxacin and Other Fluoroquinolones
2002
Grepafloxacin, a Dimethyl Derivative of Ciprofloxacin, Acts Preferentially through Gyrase in Streptococcus pneumoniae : Role of the C-5 Group in Target Specificity
2002
Engineering the Specificity of Antibacterial Fluoroquinolones: Benzenesulfonamide Modifications at C-7 of Ciprofloxacin Change Its Primary Target in Streptococcus pneumoniae from Topoisomerase IV to Gyrase
2000